The Almac Group pharmaceutical company has officially opened Asia Pacific headquarters in Singapore.
The Northern Ireland-based firm's new facilities include packaging for clinical trials as well as distribution and interactive response technology services.
It will allow Almac to better serve its clients in the region either conducting trials or expanding to international markets as well as global clients who are carrying out clinical trials in the area.
Dr Robert Dunlop, president and managing director of Almac's clinical services business unit, said: "Asia Pacific is a vital region for us, as currently 23% of global clinical trials for new pharmaceutical products are being conducted here.
"By basing our regional headquarters and operations in Singapore, we are better equipped to support our Asia-based clients in their own time zone and languages.
"With the opening of our new Singapore facility, we are directly supporting studies run by regional and global pharmaceutical firms by providing critical manufacturing, packaging, supply chain management and interactive response technology support services in Asia Pacific."
The Craigavon-headquartered company has said the new facility will strengthen the group's global footprint. It already has a presence in Europe, the US and Japan.